Literature DB >> 1207290

[Chemotherapy of cancer: the present status (author's transl)].

R Gross.   

Abstract

Especially in the treatment of solid tumors, chemotherapy with single agents has so far not been very successful. The principles and results of polychemotherapy are therefore discussed. The experimental and clinical data available suggest that there is no correlation between the number of substances combined and the therapeutic effects. The results of "blind" polychemotherapy are compared with the author's and coworkers own experimental and clinical results with partial synchronization of the tumor cells. If possible the tumor-cell kinetics are determined by a double-labeling method devised by Hilscher and Maurer. In both the experimental field (literature and our group's own examinations) and in clinical experience (still limited), partial synchronization has proved clearly superior to "blind" polychemotherapy.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1207290     DOI: 10.1007/bf01257497

Source DB:  PubMed          Journal:  Langenbecks Arch Chir        ISSN: 0023-8236


  10 in total

Review 1.  Cancer chemotherapy--the first twenty-five years.

Authors:  R B Scott
Journal:  Br Med J       Date:  1970-10-31

2.  [Studies on synchronisation in vivo: temporary inhibition of DNA synthesis in normal and malignant mammalian cell systems with hydroxyurea].

Authors:  M F Rajewsky; D F Hülser; E Fabricius
Journal:  Z Krebsforsch Klin Onkol Cancer Res Clin Oncol       Date:  1971

3.  [In vivo and in vitro studies on cell kinetics and synchronisation of human tumour cells: their significance in cytostatic tumour treatment].

Authors:  H O Klein; K J Lennartz; R Gross; M Eder; R Fischer
Journal:  Dtsch Med Wochenschr       Date:  1972-09-01       Impact factor: 0.628

4.  Cell-cycle specificity and therapeutic effectiveness of cytostatic agents.

Authors:  L M Van Putten; P Lelieveld; L K Kram-Idsenga
Journal:  Cancer Chemother Rep       Date:  1972-12

5.  Chemotherapy after synchronization of tumor cells.

Authors:  H O Klein; K J Lennartz
Journal:  Semin Hematol       Date:  1974-04       Impact factor: 3.851

Review 6.  Factors pertaining to complete drug-induced remission of tumor in animals and man.

Authors:  A Goldin
Journal:  Cancer Res       Date:  1969-12       Impact factor: 12.701

7.  Cell cycle kinetics and mitotically linked chemotherapy.

Authors:  M L Mendelsohn
Journal:  Cancer Res       Date:  1969-12       Impact factor: 12.701

8.  Implications of biochemical, cytokinetic, pharmacologic, and toxicologic relationships in the design of optimal therapeutic schedules.

Authors:  H E Skipper; F M Schabel; L B Mellett; J A Montgomery; L J Wilkoff; H H Lloyd; R W Brockman
Journal:  Cancer Chemother Rep       Date:  1970-12

9.  [Synchronization of Ehrlich ascites tumor cells and its importance in the use of an alkylating cytostatic agent].

Authors:  H O Klein; K J Lennartz; W Habicht; M Eder; R Gross
Journal:  Klin Wochenschr       Date:  1970-08-15

10.  The use of tumor growth kinetics in planning "curative" chemotherapy of advanced solid tumors.

Authors:  F M Schabel
Journal:  Cancer Res       Date:  1969-12       Impact factor: 12.701

  10 in total
  1 in total

1.  The effect of chemotherapy in relation to pathohistological tumour grading in head and neck cancer.

Authors:  K Böheim; H Spoendlin
Journal:  Arch Otorhinolaryngol       Date:  1983
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.